Skip to main content

Table 3 Comparison of laboratory indices in patients with different ARCO stages in the hormone group

From: Relationship between lipid metabolism, coagulation and other blood indices and etiology and staging of non-traumatic femoral head necrosis: a multivariate logistic regression-based analysis

Variable

ARCO II

ARCO III

ARCO IV

Test value

P value

LDL mmol/L

3.12 ± 0.47

3.27 ± 0.57

3.31 ± 0.58

4.41

0.11

N-HDL mmol/L

3.24(2.94,3.58)

3.81(3.41,4.40)

4.26(3.78,4.73)

83.90

<0.001

TG mmol/L

1.10(0.83,1.47)

1.46(0.89,1.98)

1.71(1.14,2.32)

24.92

<0.001

ApoB g/ml

1.03(0.92,1.24)

1.18(0.96,1.4)

1.3(1.02,1.49)

25.02

<0.001

ApoA1 g/ml

1.1(0.94,1.26)

1.29(1.00,1.47)

1.35(1.09,1.49)

23.77

<0.001

UA umol/L

318.00(290.80,347.50)

356.85(331.45,383.90)

384.75(360.20,407.15)

51.11

<0.001

ApoE mg/dl

3.34(3.03,4.05)

4.01(3.09,5.64)

4.70(3.29,6.92)

24.77

<0.001

ALP U/L

69.00(53.33,84.67)

72.25(55.26,88.75)

72.25(60.71,85.31)

2.58

0.276

b-ALP U/L

38.00(25.00,52.00)

42.50(32.50,53.50)

37.00(23.50,51.00)a

9.30

0.01

APTT s

24.28(23.10,25.45)

26.22(25.10,27.57)

26.09(24.49,27.17)

29.58

<0.001

PT s

10.80(9.91,11.70)

11.6(10.71,12.5)

10.45(9.38,11.43)a

51.73

<0.001

D-D ug/ml

0.32(0.23,0.38)

0.53(0.43,0.65)

1.04(0.92,1.13)

197.31

<0.001

PLT 109/L

213.65 ± 31.41

236.33 ± 46.31

197.98 ± 36.53

36.17

<0.001

  1. Date are presented as M[Q1,Q3] or mean ± SD;aP>0.05compared with ARCO stage II;bP >0.05 compared with ARCO stage II